Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jul;64(1):84–86. doi: 10.1038/bjc.1991.244

Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

L Gossner 1, H Wittke 1, A Warzecha 1, R Sroka 1, H Ernst 1, M Meier 1, C Ell 1
PMCID: PMC1977291  PMID: 1830212

Full text

PDF
84

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barr H., Bown S. G., Krasner N., Boulos P. B. Photodynamic therapy for colorectal disease. Int J Colorectal Dis. 1989;4(1):15–19. doi: 10.1007/BF01648544. [DOI] [PubMed] [Google Scholar]
  2. Begg A. C. Analysis of growth delay data: potential pitfalls. Br J Cancer Suppl. 1980 Apr;4:93–97. [PMC free article] [PubMed] [Google Scholar]
  3. Berenbaum M. C., Hall G. W., Hoyes A. D. Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer. 1986 Jan;53(1):81–89. doi: 10.1038/bjc.1986.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Garman D., Albers L., Center M. S. Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin. Biochem Pharmacol. 1983 Dec 1;32(23):3633–3637. doi: 10.1016/0006-2952(83)90315-5. [DOI] [PubMed] [Google Scholar]
  5. Gerlowski L. E., Jain R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc Res. 1986 May;31(3):288–305. doi: 10.1016/0026-2862(86)90018-x. [DOI] [PubMed] [Google Scholar]
  6. Ince P., Appleton D. R., Finney K. J., Sunter J. P., Watson A. J. Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine. Br J Cancer. 1986 Jan;53(1):137–139. doi: 10.1038/bjc.1986.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jori G., Reddi E., Cozzani I., Tomio L. Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. Br J Cancer. 1986 May;53(5):615–621. doi: 10.1038/bjc.1986.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Merry S., Fetherston C. A., Kaye S. B., Freshney R. I., Plumb J. A. Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil. Br J Cancer. 1986 Jan;53(1):129–135. doi: 10.1038/bjc.1986.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Merry S., Flanigan P., Schlick E., Freshney R. I., Kaye S. B. Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil. Br J Cancer. 1989 Jun;59(6):895–897. doi: 10.1038/bjc.1989.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mew D., Wat C. K., Towers G. H., Levy J. G. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol. 1983 Mar;130(3):1473–1477. [PubMed] [Google Scholar]
  11. Potter W. R., Mang T. S., Dougherty T. J. The theory of photodynamic therapy dosimetry: consequences of photo-destruction of sensitizer. Photochem Photobiol. 1987 Jul;46(1):97–101. doi: 10.1111/j.1751-1097.1987.tb04741.x. [DOI] [PubMed] [Google Scholar]
  12. Schmidt W. F., Huber K. R., Ettinger R. S., Neuberg R. W. Antiproliferative effect of verapamil alone on brain tumor cells in vitro. Cancer Res. 1988 Jul 1;48(13):3617–3621. [PubMed] [Google Scholar]
  13. Selman S. H., Kreimer-Birnbaum M., Klaunig J. E., Goldblatt P. J., Keck R. W., Britton S. L. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 1984 May;44(5):1924–1927. [PubMed] [Google Scholar]
  14. Sroka R., Ell C., Gottschalk W., Hengst J., Unsöld E. Homogeneous light application and monitoring of the applied power density during PDT. J Photochem Photobiol B. 1989 Jun;3(3):456–458. doi: 10.1016/1011-1344(89)80051-x. [DOI] [PubMed] [Google Scholar]
  15. Star W. M., Marijnissen H. P., van den Berg-Blok A. E., Versteeg J. A., Franken K. A., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986 May;46(5):2532–2540. [PubMed] [Google Scholar]
  16. Thomas J. P., Girotti A. W. Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative. Photochem Photobiol. 1989 Mar;49(3):241–247. doi: 10.1111/j.1751-1097.1989.tb04102.x. [DOI] [PubMed] [Google Scholar]
  17. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res. 1983 May;43(5):2267–2272. [PubMed] [Google Scholar]
  18. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]
  19. Wieman T. J., Mang T. S., Fingar V. H., Hill T. G., Reed M. W., Corey T. S., Nguyen V. Q., Render E. R., Jr Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery. 1988 Sep;104(3):512–517. [PubMed] [Google Scholar]
  20. Wooten R. S., Smith K. C., Ahlquist D. A., Muller S. A., Balm R. K. Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative. Lasers Surg Med. 1988;8(3):294–300. doi: 10.1002/lsm.1900080312. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES